First of Long Island shares slipped at the start of Thursday's trading session after the bank holding company said it will offer 1.25 million share of common stock at a price of $24 per share, a 2.3% discount to Wednesday's closing price. Underwriters were given a 30-day option to purchase up to an additional 187,500 shares to cover overallotments.
First of Long Island said net proceeds of approximately $28 million will be used for general corporate purposes, which could include contributing capital to its wholly owned bank subsidiary, the First National Bank of Long Island.
Shares of First of Long Island were higher by 54 cents, or 2.2%, to $25.10.Elsewhere, BioMimetic Therapeutics (BMTI) said it has priced an offering of 5 million shares of common stock at $8.50 per share. Underwriters were granted a 30-day option to purchase up to 750,000 additional shares to cover overallotments. BioMimetic said it expects net proceeds of approximately $40 million, which will be used to fund clinical trials for the company's product candidates, research and development activities, and completion of its manufacturing facility. Shares of BioMimetic fell by 30 cents, or 3.3%, to $8.86. Meanwhile, Jingwei International Limited (JNGW) filed for a $30 million mixed shelf offering with the Securities and Exchange Commission. Proceeds from any future offering will be used for general corporate purposes, the company said. Shares of Jingwei were lower by 3 cents, or 0.5%, to $5.87. Shares of Evolution Petroleum (EPM) were flat at $5.12 after the company filed for a $50 million mixed shelf offering. Net proceeds from the sale of any securities will be used for general corporate purposes, the company said. -- Written by Robert Holmes in Boston. Follow Robert Holmes on Twitter and become a fan of TheStreet.com on Facebook.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV